Megestrol Acetate 160 MG

DRUG3 trials

Sponsors

Cambridge University Hospitals NHS Foundation Trust, Xiaojun Chen, Fudan University

Conditions

Atypical Endometrial HyperplasiaBreast CancerEndometrial CancerFertilityFertility IssuesObese

Phase 2

A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer

CompletedNCT03306472

Cambridge University Hospitals NHS Foundation TrustBreast Cancer

Start: 2017-07-20End: 2023-10-31Updated: 2024-01-30

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

WithdrawnNCT04683237

Xiaojun ChenAtypical Endometrial Hyperplasia, Fertility Issues, Obese

Start: 2021-03-20End: 2026-11-30Updated: 2024-09-26

Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification

RecruitingNCT07319429

Fudan UniversityEndometrial Cancer, Fertility

Start: 2026-01-25End: 2029-12-31Target: 260Updated: 2026-03-13

Related Papers

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

2026-01-05